FINWIRES · TerminalLIVE
FINWIRES

Fears of Another Interest Rate Hike Batter Australian Consumer Confidence

By
Fears of Another Interest Rate Hike Batter Australian Consumer Confidence

Fears over a further increase in borrowing costs are unnerving Australians, with a decline in two measures of consumer confidence reflecting those concerns in addition to continued cost-of-living pressures.

The Westpac-Melbourne Institute consumer sentiment index fell to 84.4 in September from 88.9 in the previous month, taking views back toward "deeply pessimistic" territory seen earlier this year, Westpac said Tuesday.

A Westpac index tracking consumer interest rate expectations rose more than 7% to 170.4 in September, as around 64% of consumers now believe mortgage rates will rise further over the next 12 months, up from 59% in August, Westpac said.

Higher fuel costs also weighed on sentiment, as Australian pump prices again rose above AU$2 per liter for the first time since April following the end of a temporary measure that halved fuel excise tax. The bank's survey further pointed to unease over job security, particularly among construction and hospitality workers.

A separate gauge from ANZ-Roy Morgan mirrored some of those findings, showing consumer confidence falling 3 points last week to 71.9, the lowest level since late July.

Both surveys follow a stronger-than-expected monthly consumer price index reading in July and more recent gross domestic product data that showed Australia's economy growing slightly below potential. The prospect of another rate hike this year combined with the GDP data may have contributed to weaker sentiment, ANZ said.

ANZ still expects the Reserve Bank of Australia to raise its official cash rate by 25 basis points in November. While Westpac also acknowledged the increased likelihood of a future rate hike, it said the central bank is unlikely to move at its September meeting based on one monthly inflation read alone, especially as the next inflation update is due a day after that meeting.

Related Articles

Ingenia Communities Rejects Warburg Pincus' AU$1.94 Billion Takeover Bid
US Markets

Ingenia Communities Rejects Warburg Pincus' AU$1.94 Billion Takeover Bid

Ingenia Communities (ASX:INA) has rejected Walberg Pincus' unsolicited offer to take over the property group for AU$1.94 billion, saying the proposal "substantially undervalues" the company, according to a Monday filing with the Australian Securities Exchange.The conditional, non-binding proposal, which would take the property group for AU$4.75 per security, "is not in the best interests of its security holders," Ingenia said.Ingenia said it is optimistic about its strategy, underpinned by support from its land lease and holiday accommodation sectors. The company will have opportunities to grow and give long-term value to shareholders, the developer added.The proposal is subject to due diligence, regulatory approvals, and board recommendation, and is contingent on the company abandoning its proposed acquisition of residential developer Peet (ASX:PPC).In late August, Ingenia offered to purchase Peet for AU$0.68 per share and scrip consideration of 0.3367 Ingenia stapled securities per Peet share, valuing Ingenia's peer at AU$992.5 million.Shares in Ingenia surged 14% during the midday session in Sydney.

ASX:INA
Fosun Pharma Plans HK$1 Billion Share Buyback Funded by Gland Pharma Stake Sale
US Markets

Fosun Pharma Plans HK$1 Billion Share Buyback Funded by Gland Pharma Stake Sale

Shanghai Fosun Pharmaceutical (HKG:2196, SHA:600196) plans to repurchase up to HK$1 billion of its H-shares over a 12-month period.The plan, which the Chinese pharmaceutical firm said was designed to address market concerns and bolster shareholder value, will be funded by a divestment in its Indian unit.Fosun's indirect subsidiary, Fosun Pharma Singapore, sold 9.897 million shares in Gland Pharma (NSE:GLAND, BOM:543245) for about 28 billion Indian rupees. The sale was executed through block trades and open-market transactions at an average price of 2,828.78 rupees each, representing a 2.72% discount to the previous close.The sale reduces Fosun International's equity stake in Gland Pharma to 45.76% from 51.76%. Gland Pharma will remain a subsidiary of Fosun Pharma and its financial results will continue to be consolidated under Fosun's umbrella.The share buyback follows an upbeat first half for Fosun Pharma. Attributable net profit jumped 19.1% year over year to 1.14 billion yuan on the back of a 4.75% increase in revenue to 20.4 billion yuan."Looking ahead, Fosun Pharma will stay focused on innovation and globalization, accelerating the R&D progress and commercialization of its major pipeline candidates," the company said.Fosun Pharma's shares jumped more than 7% in Hong Kong and over 1% in Shanghai in recent trade.

BOM:543245HKG:2196NSE:GLANDSHA:600196
Australian Job Ads Rise in August, But Poised to Trend Lower as Economic Momentum Fades
US Markets

Australian Job Ads Rise in August, But Poised to Trend Lower as Economic Momentum Fades

Labor demand in Australia remained resilient in August with a rise in the number of job advertisements, but the volume of ads is expected to trend lower over the coming months as the impact of the central bank's monetary tightening takes hold.ANZ-Indeed Australian Job Ads, a monthly indicator that tracks the total number of internet job advertisements across select websites, rose by a seasonally adjusted 2.5% month over month in August following an upwardly revised 1.9% increase in July, ANZ Research said in a Monday release.The growth was driven by notable gains across Victoria, Western Australia, and Queensland as local businesses started Christmas-related hiring, leading to a surge in retail and food service roles, the data showed.The education and cleaning and sanitation sectors also posted strong gains, but tech-related hiring continued to slow, with software development, data and analytics, and other tech roles seeing a modest decline in demand in recent months.But as labor market conditions typically respond to changes in economic activity with a lag, ANZ expects job ad volume to gradually decline as economic momentum softens and higher interest rates act as a restraint on demand.The Reserve Bank of Australia raised borrowing costs three times this year, but held the rate at 4.35% at its two most recent meetings in June and August. More hikes may be on the cards as policymakers remain concerned about upside risks to inflation, which remains above target.Australia's seasonally adjusted unemployment rate increased to 4.5% in July from 4.4% in the previous month as employment fell by 15,800 people, official Australian Bureau of Statistics data showed in August."While the ABS highlighted larger-than-usual uncertainty around the estimates, we continue to expect labor market conditions to ease and unemployment to drift higher gradually over the months ahead," said Jasmine Zheng, a senior economist at ANZ. But given the resilience of the ANZ-Indeed series, "we expect the rise in the unemployment rate to be modest," Zheng said.

ASX 200